ABBV vs HD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and The Home Depot, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C
High Quality
VS
The Home Depot, Inc. · Consumer Cyclical
$302.44
+22.0% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
HD has more upside to fair value
(+22.0%).
HD trades at a lower forward P/E
(20.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
HD |
| Current Price |
$197.69 |
$302.44 |
| Fair Value Estimate |
$210.22 |
$369.00 |
| Upside to Fair Value |
+6.3%
|
+22.0%
|
| Market Cap |
$349.7B |
$301.2B |
| Forward P/E |
83.3x
|
20.5x
|
| EV / EBITDA |
23.4x
|
16.5x
|
| Price / Sales |
5.7x
|
2.0x
|
| Price / FCF |
18.7x
|
26.6x
|
| Revenue Growth YoY |
+10.0%
|
+4.8%
|
| Gross Margin |
70.2%
|
33.3%
|
| Operating Margin |
26.7%
|
12.7%
|
| Return on Equity |
-361.6%
|
110.5%
|
| Dividend Yield |
0% |
2.72% |
| FCF Yield |
5.35%
|
3.75%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
Home Depot remains the world's largest home improvement retailer with 2,350+ stores, dominant 52% market share, and an expanding Pro contractor segment bolstered by the SRS Distribution acquisition. Q1 FY2026 results released May 19 beat both the top and bottom line, with revenue of $41.77B up 4.8% year over year and adjusted EPS of $3.43 versus the $3.41 consensus. Comp sales grew only 0.6% howe…
Accumulation Zones
| Metric |
ABBV |
HD |
| Zone Low |
$157.66 |
$276.75 |
| Zone High |
$178.69 |
$313.65 |
| In Buy Zone? |
No
|
Yes
|